Asymmetric division rejuvenates stem cell lineages.
Cell Res.
2026 Apr;36(4):239-240. doi: 10.1038/s41422-026-01226-8. PubMed PMID:
41692871; PubMed Central PMCID:
PMC13013559.
WDR5 remodels NANOG condensates to drive transcriptional programs and sustain stem cell identity.
Nat Commun.
2026 Jan 21;17(1). doi: 10.1038/s41467-026-68623-w. PubMed PMID:
41565645; PubMed Central PMCID:
PMC12923824.
Paraspeckle component 1 in acute myeloid leukemia: prospects for therapeutic targeting.
Expert Opin Ther Targets.
2026 Jan;30(1):13-17. doi: 10.1080/14728222.2025.2608021. Epub 2025 Dec 29. PubMed PMID:
41432453; NIHMSID:NIHMS2159805.
Editorial overview: 3Rs update: a new era in cellular identity and therapeutic plasticity.
Curr Opin Genet Dev.
2025 Oct;94:102386. doi: 10.1016/j.gde.2025.102386. Epub 2025 Aug 5. PubMed PMID:
40768826.
Totipotency or plenipotency: rethinking stem cell bipotentiality.
Curr Opin Genet Dev.
2025 Jun;92:102342. doi: 10.1016/j.gde.2025.102342. Epub 2025 Mar 19. Review. PubMed PMID:
40107116; PubMed Central PMCID:
PMC12279028.
Structure-function relationship of ASH1L and histone H3K36 and H3K4 methylation.
Nat Commun.
2025 Mar 6;16(1):2235. doi: 10.1038/s41467-025-57556-5. PubMed PMID:
40044670; PubMed Central PMCID:
PMC11883000.
Pluripotency factor Tex10 finetunes Wnt signaling for spermatogenesis and primordial germ cell development.
Nat Commun.
2025 Feb 23;16(1):1900. doi: 10.1038/s41467-025-57165-2. PubMed PMID:
39988597; PubMed Central PMCID:
PMC11847947.
PSPC1 exerts an oncogenic role in AML by regulating a leukemic transcription program in cooperation with PU.1.
Cell Stem Cell.
2025 Mar 6;32(3):463-478.e6. doi: 10.1016/j.stem.2025.01.010. Epub 2025 Feb 14. PubMed PMID:
39954676; PubMed Central PMCID:
PMC12097264.
DDX18 coordinates nucleolus phase separation and nuclear organization to control the pluripotency of human embryonic stem cells.
Nat Commun.
2024 Dec 30;15(1):10803. doi: 10.1038/s41467-024-55054-8. PubMed PMID:
39738032; PubMed Central PMCID:
PMC11685540.
RNA m(5)C oxidation by TET2 regulates chromatin state and leukaemogenesis.
Nature.
2024 Oct;634(8035):986-994. doi: 10.1038/s41586-024-07969-x. Epub 2024 Oct 2. PubMed PMID:
39358506; PubMed Central PMCID:
PMC11499264.
NAC1 promotes stemness and regulates myeloid-derived cell status in triple-negative breast cancer.
Mol Cancer.
2024 Sep 6;23(1):188. doi: 10.1186/s12943-024-02102-y. PubMed PMID:
39243032; PubMed Central PMCID:
PMC11378519.
Loss of the stress sensor GADD45A promotes stem cell activity and ferroptosis resistance in LGR4/HOXA9-dependent AML.
Blood.
2024 Jul 4;144(1):84-98. doi: 10.1182/blood.2024024072. PubMed PMID:
38579286; PubMed Central PMCID:
PMC11251412.
ZFP281 controls transcriptional and epigenetic changes promoting mouse pluripotent state transitions via DNMT3 and TET1.
Dev Cell.
2024 Feb 26;59(4):465-481.e6. doi: 10.1016/j.devcel.2023.12.018. Epub 2024 Jan 17. PubMed PMID:
38237590; PubMed Central PMCID:
PMC10923053.
Mild sleep restriction increases endothelial oxidative stress in female persons.
Sci Rep.
2023 Sep 16;13(1):15360. doi: 10.1038/s41598-023-42758-y. PubMed PMID:
37717072; PubMed Central PMCID:
PMC10505226.
An intellectual-disability-associated mutation of the transcriptional regulator NACC1 impairs glutamatergic neurotransmission.
Front Mol Neurosci.
2023;16:1115880. doi: 10.3389/fnmol.2023.1115880. eCollection 2023. Review. PubMed PMID:
37533751; PubMed Central PMCID:
PMC10393139.
ZFP281 coordinates DNMT3 and TET1 for transcriptional and epigenetic control in pluripotent state transitions.
bioRxiv.
2023 Mar 25;. doi: 10.1101/2023.03.24.534143. PubMed PMID:
36993548; PubMed Central PMCID:
PMC10055359.
The pluripotency factor Tex10 finetunes Wnt signaling for PGC and male germline development.
bioRxiv.
2023 Feb 24;. doi: 10.1101/2023.02.23.529824. PubMed PMID:
36865339; PubMed Central PMCID:
PMC9980098.
An RNAi screen of RNA helicases identifies eIF4A3 as a regulator of embryonic stem cell identity.
Nucleic Acids Res.
2022 Nov 28;50(21):12462-12479. doi: 10.1093/nar/gkac1084. PubMed PMID:
36416264; PubMed Central PMCID:
PMC9757061.
A MYC-ZNF148-ID1/3 regulatory axis modulating cancer stem cell traits in aggressive breast cancer.
Oncogenesis.
2022 Oct 7;11(1):60. doi: 10.1038/s41389-022-00435-1. PubMed PMID:
36207293; PubMed Central PMCID:
PMC9546828.
ZFP281 drives a mesenchymal-like dormancy program in early disseminated breast cancer cells that prevents metastatic outgrowth in the lung.
Nat Cancer.
2022 Oct;3(10):1165-1180. doi: 10.1038/s43018-022-00424-8. Epub 2022 Sep 1. PubMed PMID:
36050483.
Comparative functional genomics identifies unique molecular features of EPSCs.
Life Sci Alliance.
2022 Nov;5(11). doi: 10.26508/lsa.202201608. Print 2022 Nov. PubMed PMID:
35961778; PubMed Central PMCID:
PMC9378845.
NAC1 modulates autoimmunity by suppressing regulatory T cell-mediated tolerance.
Sci Adv.
2022 Jul;8(26):eabo0183. doi: 10.1126/sciadv.abo0183. Epub 2022 Jun 29. PubMed PMID:
35767626; PubMed Central PMCID:
PMC9242588.
A TET1-PSPC1-Neat1 molecular axis modulates PRC2 functions in controlling stem cell bivalency.
Cell Rep.
2022 Jun 7;39(10):110928. doi: 10.1016/j.celrep.2022.110928. PubMed PMID:
35675764; PubMed Central PMCID:
PMC9214724.
Pursuing totipotency: authentic totipotent stem cells in culture.
Trends Genet.
2022 Jul;38(7):632-636. doi: 10.1016/j.tig.2022.03.012. Epub 2022 Apr 18. PubMed PMID:
35443932; PubMed Central PMCID:
PMC9197991.
eIF4A2 targets developmental potency and histone H3.3 transcripts for translational control of stem cell pluripotency.
Sci Adv.
2022 Apr;8(13):eabm0478. doi: 10.1126/sciadv.abm0478. Epub 2022 Mar 30. PubMed PMID:
35353581; PubMed Central PMCID:
PMC8967233.
Phase separation of RNA-binding protein promotes polymerase binding and transcription.
Nat Chem Biol.
2022 Jan;18(1):70-80. doi: 10.1038/s41589-021-00904-5. Epub 2021 Dec 16. PubMed PMID:
34916619.
Zfp281 is essential for epiblast maturation through a cell autonomous effect.
J Genet Genomics.
2022 Jan;49(1):85-88. doi: 10.1016/j.jgg.2021.08.016. Epub 2021 Sep 17. PubMed PMID:
34543730; PubMed Central PMCID:
PMC9085266.
OCT4 cooperates with distinct ATP-dependent chromatin remodelers in naïve and primed pluripotent states in human.
Nat Commun.
2021 Aug 26;12(1):5123. doi: 10.1038/s41467-021-25107-3. PubMed PMID:
34446700; PubMed Central PMCID:
PMC8390644.
LIN28 coordinately promotes nucleolar/ribosomal functions and represses the 2C-like transcriptional program in pluripotent stem cells.
Protein Cell.
2022 Jul;13(7):490-512. doi: 10.1007/s13238-021-00864-5. Epub 2021 Jul 31. PubMed PMID:
34331666; PubMed Central PMCID:
PMC9226220.
Phase separation of OCT4 controls TAD reorganization to promote cell fate transitions.
Cell Stem Cell.
2021 Oct 7;28(10):1868-1883.e11. doi: 10.1016/j.stem.2021.04.023. Epub 2021 May 25. PubMed PMID:
34038708.
ZFP281 recruits polycomb repressive complex 2 to restrict extraembryonic endoderm potential in safeguarding embryonic stem cell pluripotency.
Protein Cell.
2021 Mar;12(3):213-219. doi: 10.1007/s13238-020-00775-x. PubMed PMID:
32812113; PubMed Central PMCID:
PMC7895869.
Functional role of Tet-mediated RNA hydroxymethylcytosine in mouse ES cells and during differentiation.
Nat Commun.
2020 Oct 2;11(1):4956. doi: 10.1038/s41467-020-18729-6. PubMed PMID:
33009383; PubMed Central PMCID:
PMC7532169.
Context dependent effects of ascorbic acid treatment in TET2 mutant myeloid neoplasia.
Commun Biol.
2020 Sep 7;3(1):493. doi: 10.1038/s42003-020-01220-9. PubMed PMID:
32895473; PubMed Central PMCID:
PMC7477582.
An Optimized Immunoprecipitation Protocol for Assessing Protein-RNA Interactions In Vitro.
STAR Protoc.
2020 Sep 18;1(2). doi: 10.1016/j.xpro.2020.100093. Epub 2020 Aug 26. PubMed PMID:
32995755; PubMed Central PMCID:
PMC7521669.
Targeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid Leukemia.
Cancer Cell.
2020 Aug 10;38(2):263-278.e6. doi: 10.1016/j.ccell.2020.05.014. Epub 2020 Jun 18. PubMed PMID:
32559496.
Ribosome heterogeneity in stem cells and development.
J Cell Biol.
2020 Jun 1;219(6). doi: 10.1083/jcb.202001108. Review. PubMed PMID:
32330234; PubMed Central PMCID:
PMC7265316.
ADAR1-Dependent RNA Editing Promotes MET and iPSC Reprogramming by Alleviating ER Stress.
Cell Stem Cell.
2020 Aug 6;27(2):300-314.e11. doi: 10.1016/j.stem.2020.04.016. Epub 2020 May 11. PubMed PMID:
32396862; PubMed Central PMCID:
PMC7415614.
Regulation of pluripotency and reprogramming by RNA binding proteins.
Curr Top Dev Biol.
2020;138:113-138. doi: 10.1016/bs.ctdb.2020.01.003. Epub 2020 Feb 25. Review. PubMed PMID:
32220295; PubMed Central PMCID:
PMC8015705.
DUX-miR-344-ZMYM2-Mediated Activation of MERVL LTRs Induces a Totipotent 2C-like State.
Cell Stem Cell.
2020 Feb 6;26(2):234-250.e7. doi: 10.1016/j.stem.2020.01.004. PubMed PMID:
32032525; PubMed Central PMCID:
PMC8074926.
The roles of TET family proteins in development and stem cells.
Development.
2020 Jan 15;147(2). doi: 10.1242/dev.183129. Review. PubMed PMID:
31941705; PubMed Central PMCID:
PMC6983710.
DEAD-Box Helicase 18 Counteracts PRC2 to Safeguard Ribosomal DNA in Pluripotency Regulation.
Cell Rep.
2020 Jan 7;30(1):81-97.e7. doi: 10.1016/j.celrep.2019.12.021. PubMed PMID:
31914400.
Zfp281 (ZBP-99) plays a functionally redundant role with Zfp148 (ZBP-89) during erythroid development.
Blood Adv.
2019 Aug 27;3(16):2499-2511. doi: 10.1182/bloodadvances.2018030551. PubMed PMID:
31455666; PubMed Central PMCID:
PMC6712527.
miR-101 suppresses the development of MLL-rearranged acute myeloid leukemia.
Haematologica.
2019 Jul;104(7):e296-e299. doi: 10.3324/haematol.2018.209437. Epub 2019 Feb 21. PubMed PMID:
30792205; PubMed Central PMCID:
PMC6601101.
JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesis.
Leukemia.
2019 Jun;33(6):1400-1410. doi: 10.1038/s41375-018-0354-z. Epub 2019 Jan 8. PubMed PMID:
30622285.
Uhrf1 regulates active transcriptional marks at bivalent domains in pluripotent stem cells through Setd1a.
Nat Commun.
2018 Jul 3;9(1):2583. doi: 10.1038/s41467-018-04818-0. PubMed PMID:
29968706; PubMed Central PMCID:
PMC6030064.
Endothelial cells instruct liver specification of embryonic stem cell-derived endoderm through endothelial VEGFR2 signaling and endoderm epigenetic modifications.
Stem Cell Res.
2018 Jul;30:163-170. doi: 10.1016/j.scr.2018.06.004. Epub 2018 Jun 21. PubMed PMID:
29936335.
YY1 Positively Regulates Transcription by Targeting Promoters and Super-Enhancers through the BAF Complex in Embryonic Stem Cells.
Stem Cell Reports.
2018 Apr 10;10(4):1324-1339. doi: 10.1016/j.stemcr.2018.02.004. Epub 2018 Mar 1. PubMed PMID:
29503092; PubMed Central PMCID:
PMC5998734.
RNA-dependent chromatin targeting of TET2 for endogenous retrovirus control in pluripotent stem cells.
Nat Genet.
2018 Mar;50(3):443-451. doi: 10.1038/s41588-018-0060-9. Epub 2018 Feb 26. PubMed PMID:
29483655; PubMed Central PMCID:
PMC5862756.
Dynamic epigenomic landscapes during early lineage specification in mouse embryos.
Nat Genet.
2018 Jan;50(1):96-105. doi: 10.1038/s41588-017-0003-x. Epub 2017 Dec 4. PubMed PMID:
29203909.
Zfp281 is essential for mouse epiblast maturation through transcriptional and epigenetic control of Nodal signaling.
Elife.
2017 Nov 23;6. doi: 10.7554/eLife.33333. PubMed PMID:
29168693; PubMed Central PMCID:
PMC5708896.
What would you like to do?